VITAE PHARMACEUT (VTAE)

HEALTH CARE: HEALTH CARE
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

502 WEST OFFICE CENTER DR FORT WASHINGTON, PA 19034

Vitae Pharmaceuticals, Inc. offers clinical-stage biopharmaceutical products. The Company develops small molecule compounds that address medical needs such as chronic kidney disease, diabetes, atherosclerosis, and Alzheimer's diseases.

View SEC Filings from VTAE instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding VTAE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VTAE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SANTINI GINO

  • Director
No longer subject to file 2016-10-25 0

GREGG RICHARD CHIEF SCIENCE OFFICER

  • Officer
No longer subject to file 2016-10-25 0

ROWLAND CHARLES A JR

  • Director
No longer subject to file 2016-10-25 0

HAYDEN DONALD J JR

  • Director
No longer subject to file 2016-10-25 0

MORRIS RICHARD STEVEN CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2016-10-25 0

LEONARD JOHN M.

  • Director
No longer subject to file 2016-10-25 0

BERNSTEIN KAREN

  • Director
No longer subject to file 2016-10-25 0

SABLE CAROLE CHIEF MEDICAL OFFICER

  • Officer
No longer subject to file 2016-10-25 0

JUNIUS DANIEL M

  • Director
No longer subject to file 2016-10-25 0

APPLEBAUM SCOTT GENERAL COUNSEL

  • Officer
No longer subject to file 2016-10-25 0

HATFIELD JEFFREY S. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
No longer subject to file 2016-10-24 0

FRATAMICO ARTHUR CHIEF BUSINESS OFFICER

  • Officer
No longer subject to file 2016-10-24 0

GUNDERSON ROBERT V JR

  • Director
No longer subject to file 2016-10-24 0

ADAGE CAPITAL PARTNERS GP, L.L.C.

ADAGE CAPITAL PARTNERS, L.P.

ADAGE CAPITAL ADVISORS, L.L.C.

ATCHINSON ROBERT

GROSS PHILLIP

  • 10% Owner
No longer subject to file 2016-09-14 0

ROBERTS BRYAN E

  • Director
0 2016-05-26 0

NEWHALL CHARLES W III

  • Director
289 2015-07-01 0

NEW ENTERPRISE ASSOCIATES 10 L P

  • 10% Owner
No longer subject to file 2015-07-01 0

NEA PARTNERS 10 L P

  • 10% Owner
No longer subject to file 2015-07-01 0

SANDELL SCOTT D

  • 10% Owner
No longer subject to file 2015-07-01 0

BARRETT M JAMES

  • 10% Owner
No longer subject to file 2015-07-01 0

BARRIS PETER J

  • 10% Owner
No longer subject to file 2015-07-01 0

PROSPECT MANAGEMENT CO II LLC

PROSPECT VENTURE PARTNERS II LP

PROSPECT VENTURE PARTNERS LP

PROSPECT MANAGEMENT CO LLC

HIRSCH RUSSELL C

SCHNELL DAVID

  • 10% Owner
No longer subject to file 2015-03-24 0

VENROCK MANAGEMENT III LLC

VENROCK ASSOCIATES III LP

VENROCK ASSOCIATES

VENROCK ENTREPRENEURS FUND III LP

VEF MANAGEMENT III LLC

  • 10% Owner
5,734,877 2014-09-29 0

NEW ENTERPRISE ASSOCIATES 10 L P

NEA PARTNERS 10 L P

BARRIS PETER J

BARRETT M JAMES

SANDELL SCOTT D

  • 10% Owner
2,611,564 2014-09-29 0

BARRETT PETER

  • Director
1,174,315 2014-09-29 0

PROSPECT MANAGEMENT CO II LLC

PROSPECT MANAGEMENT CO LLC

HIRSCH RUSSELL C

SCHNELL DAVID

  • 10% Owner
63,041 2014-09-24 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments